References
- Chen, J. H., Pan, W. H., Hsu, C. C., Yeh, W. T., Chuang, S. Y., Chen, P. Y., … Huang, W. L. (2013). Impact of obesity and hypertriglyceridemia on gout development with or without hyperuricemia: A prospective study. Arthritis Care & Research, 65(1), 133–140. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22933424
- Choi, H. K., & Curhan, G. (2005). Gout: Epidemiology and lifestyle choices. Current Opinion in Rheumatology, 17(3), 341–345. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15838248
- Coburn, B. W., Bendlin, K. A., Sayles, H., Hentzen, K. S., Hrdy, M. M., & Mikuls, T. R. (2016). Target serum urate: do gout patients know their goal? Arthritis Care & Research, 68(7), 1028–1035. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26784147
- Fu, Q. L., Ma, J. X., Ou, C. Q., Guo, C., Shen, S. Q., Xu, G., & Shi, J. (2015). Influence of self-reported chronic rhinosinusitis on health-related quality of life: A population-based survey. PloS One, 10(5), e0126881. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25978550
- Gelber, R. P., Gaziano, J. M., Orav, E. J., Manson, J. E., Buring, J. E., & Kurth, T. (2008). Measures of obesity and cardiovascular risk among men and women. Journal of the American College of Cardiology, 52(8), 605–615. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/18702962
- Khanna, D., Fitzgerald, J. D., Khanna, P. P., Bae, S., Singh, M. K., Neogi, T., … Terkeltaub, R., American College of, R. (2012). 2012 American college of rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care & Research, 64(10), 1431–1446. . Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23024028.
- Kubomura, D., Yamada, M., & Masui, A. (2016). Tuna extract reduces serum uric acid in gout-free subjects with insignificantly high serum uric acid: A randomized controlled trial. Biomedical Reports, 5(2), 254–258. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27446553
- Kuo, C. F., Grainge, M. J., See, L. C., Yu, K. H., Luo, S. F., Valdes, A. M., … Doherty, M. (2015). Familial aggregation of gout and relative genetic and environmental contributions: A nationwide population study in Taiwan. Annals of the Rheumatic Diseases, 74(2), 369–374. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/24265412
- Kuo, C. F., Grainge, M. J., Zhang, W., & Doherty, M. (2015). Global epidemiology of gout: Prevalence, incidence and risk factors. Nature Reviews Rheumatology, 11(11), 649–662. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/26150127
- McElfish, P. A., Rowland, B., Long, C. R., Hudson, J., Piel, M., Buron, B., … Warmack, T. S. (2017). Diabetes and hypertension in marshallese adults: Results from faith-based health screenings. Journal of Racial and Ethnic Health Disparities, 4(6), 1042–1050. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/27837454
- Millwood, I. Y., Li, L., Smith, M., Guo, Y., Yang, L., Bian, Z., … Peng, Y., China Kadoorie Biobank collaborative, g. (2013). Alcohol consumption in 0.5 million people from 10 diverse regions of China: Prevalence, patterns and socio-demographic and health-related correlates. International Journal of Epidemiology, 42(3), 816–827. . Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23918852.
- Perez-Ruiz, F., & Herrero-Beites, A. M. (2012). Evaluation and treatment of gout as a chronic disease. Advances in Therapy, 29(11), 935–946. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23104464
- Quilis, N., Andres, M., Gil, S., Ranieri, L., Vela, P., & Pascual, E. (2016). Febuxostat for patients with gout and severe chronic kidney disease: Which is the appropriate dosage? Comment on the article by Saag et al. Arthritis & Rheumatology, 68(10), 2563–2564. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27273838
- Rott, K. T., & Agudelo, C. A. (2003). Gout. JAMA, 289(21), 2857–2860. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12783917
- Sheng, F., Fang, W., Zhang, B., Sha, Y., & Zeng, X. (2017). Adherence to gout management recommendations of Chinese patients. Medicine, 96(45), e8532. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/29137059
- Sherman, M. R., Saifer, M. G., & Perez-Ruiz, F. (2008). PEG-uricase in the management of treatment-resistant gout and hyperuricemia. Advanced Drug Delivery Reviews, 60(1), 59–68. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17826865
- Shoji, A., Yamanaka, H., & Kamatani, N. (2004). A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: Evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis and Rheumatism, 51(3), 321–325. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15188314
- Singh, J. A. (2014). The impact of gout on patient’s lives: A study of African-American and Caucasian men and women with gout. Arthritis Research & Therapy, 16(3), R132. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/24961941
- Stiburkova, B., & Bleyer, A. J. (2012). Changes in serum urate and urate excretion with age. Advances in Chronic Kidney Disease, 19(6), 372–376. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23089271
- Takahashi, S., Yamamoto, T., Tsutsumi, Z., Moriwaki, Y., Yamakita, J., & Higashino, K. (1997). Close correlation between visceral fat accumulation and uric acid metabolism in healthy men. Metabolism, 46(10), 1162–1165. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9322800
- Zhai, F. Y., Zhang, L. W., Wang, C. R., Duan, J. L., Cao, R. X., Wang, H. J., & Zhang, J. (2004). [Validation of lipids on body mass index reference recommended by obesity working group, international life science association of China]. Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi, 25(2), 117–119. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15132862
- Zhang, W., Doherty, M., Bardin, T., Pascual, E., Barskova, V., & Conaghan, P., Therapeutics, E. S. C. f. I. C. S. I. (2006). EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Annals of the Rheumatic Diseases, 65(10), 1312–1324. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16707532.
- Zhu, Y., Pandya, B. J., & Choi, H. K. (2012). Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007–2008. The American Journal of Medicine, 125(7), 679–687 e671. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22626509